U.K. becomes the first to sequence 100,000 whole human genomes at scale for healthcare, opening up new opportunities for precision medicine

December 06, 2018
Digital Transformation More...
Very important

The U.K. has become the first nation in the world to sequence 100,000 human genomes at scale for healthcare, in partnership with Illumina. The 100,000 Genomes Project has already benefited patients by identifying rare genetic mutations in children that are otherwise difficult to diagnose by standard tests, allowing timely and effective interventions that save lives. Business opportunities clearly exist in public-private partnerships, as this success story with Illumina and the U.K. illustrates. This development will spur other global precision medicine initiatives, offering similar business opportunities for clients. Precision medicine is in Lux's 19 for 2019; clients should consider public-private partnership as a market access strategy.

For the original news article, click here .

Further Reading

FDA authorizes emergency use of Lucira's at-home test kit – with results in 30 minutes and no shipping to a lab

News Commentary | November 25, 2020

This advancement in POC testing is one that decentralizes the testing process and allows for nearly immediate self‑quarantine and thereby reducing the burden on shipping and laboratory infrastructure. While clients may want to take note of this development for use for their own employees, clients ... To read more, click here.

Wales enables digital access to genomic tests for cancer patients

News Commentary | July 29, 2021

The initiative is run by Digital Health and Care Wales (DHCW), a government special health authority, and enabled by the Welsh Clinical Portal (WCP), which allows doctors to access the genetic tests of cancer patients. The DHCW claims the move aids multidisciplinary teams in decentralized locations ... Not part of subscription

Australia launches pilot genomic testing study for early cancer screening

News Commentary | August 06, 2021

The program targets healthy adults aged 18 to 40 and will offer low‑cost DNA tests for 10,000 Australians. The move serves to proactively identify people at risk for cancer as well as establish a foundation for preventative DNA screening in the country. A similar program in the U.K was able to ... Not part of subscription